AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Viagene Inc. announced that Robert T. Abbott has been named president and chief executive officer.
Abbott was formerly president and chief executive officer of NeoRx Corp., a Seattle-based biotechnology company involved in the development of monoclonal antibody-based imaging and therapeutic products.
"Bob has significant experience in the biopharmaceutical industry," said David F. Hale, chairman of Viagene. "His proven ability to raise the capital necessary to build a biopharmaceutical company will be very important to the continued successful development of Viagene's gene transfer technology.
"His experience in effectively …